Macc1 as a prognostic biomarker for hepatobiliary tumors
CN104822391A
Magnetic nanoparticles dispersion, its preparation and diagnostic and therapeutic use
WO2013117581A1
Metabolically stable variants of chemerin 9
WO2013020877A1
Medical device
WO2013007556A1
Method and device for determining target brain segments in human or animal brains
DE102012105416A1
Modifying glycosylation profile of a glycosylation site contained in a target peptide, comprises recombinantly producing a fusion protein made of a mint protein and the target peptide, which contains predetermined glycosylation site
EP2647389A1
Magnetic nanoparticle dispersion, its preparation and diagnostic and therapeutic use
WO2013131577A1
Applicator for medical thermotherapy
WO2013131578A1
Endoscopic multifunction device for medical therapy
DE102012101557A1
Use of microRNAs or genes as markers for the identification, diagnosis and therapy of individual non-ischemic cardiomyopathies or memory diseases of the heart
EP2631653A1
Identification of modulators of binding properties of antibodies reactive with a member of the insulin receptor family
EP2628791A1
Perfusion module for the co-culture of endothelial cells and smooth muscle cells for determining patho-physiological changes
EP2623978A1
CD8+ T-cell subsets as markers for prediction of delayed fracture healing
DE102011089401A1
Method for examining human or animal tissue
WO2012089571A1
Method and device for visualizing human or animal brain segments
WO2012048895A2
Device for the therapy of peripheral circulatory disorders in the region of the lower extremities
DE102011118015A1
IgY composition for use in celiac disease
DE102011112898A1
Nanoparticulate phosphate adsorbent based on maghemite or maghemite / magnetite, its preparation and uses
EP2559685A1
Fentanyl derivatives as pH-dependent opioid receptor agonists
DE102011078700A1
Dialysis procedure for removing protein-bound toxins from the blood of acute or chronic renal failure patients
